Skip to content
If you can read this, either the style sheet didn't load or you have an older browser that doesn't support style sheets. Try clearing your browser cache and refreshing the page.

(Yahoo)   FDA restricts new Alzheimer's drug to only mild cases, for fear that its inconclusive efficacy data + stratospheric price would bankrupt the US Gov't   ( divider line
    More: Followup, Clinical trial, Alzheimer's disease, Drug Administration, Biogen Inc, Food and Drug Administration, new label, Biogen's Aduhelm, use of its Alzheimer  
•       •       •

664 clicks; posted to STEM » on 09 Jul 2021 at 6:04 AM (1 year ago)   |   Favorite    |   share:  Share on Twitter share via Email Share on Facebook

Voting Results (Funniest)
View Voting Results: Smartest and Funniest

2021-07-09 6:15:27 AM  
2 votes:
When I was a kid, I always thought they were saying "Oldtimer's Disease."

2021-07-09 7:16:42 AM  
1 vote:
If only we had a functioning government, Biogen could get insanely wealthy and everyone who needs it could get the medicine.  Instead Biogen gets stupidly wealthy and only the very richest get it.
2021-07-09 7:56:23 AM  
1 vote:
priced at $56,000 a year

A small price to pay for regaining the requisite faculties to fully appreciate how much debt you've put yourself in.
2021-07-09 9:59:09 AM  
1 vote:

sleze: When I was a kid, I always thought they were saying "Oldtimer's Disease."


My Korean wife is almost 70 years old, and she still calls it that.
Displayed 4 of 4 comments

View Voting Results: Smartest and Funniest

This thread is archived, and closed to new comments.

Continue Farking

On Twitter

  1. Links are submitted by members of the Fark community.

  2. When community members submit a link, they also write a custom headline for the story.

  3. Other Farkers comment on the links. This is the number of comments. Click here to read them.

  4. Click here to submit a link.